Navigation Links
Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results
Date:8/11/2009

BEIJING, Aug. 11 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of vaccines in China, today announced that it will host a conference call on Wednesday, August 19, 2009 at 8:00 a.m. ET to review the Company's second quarter financial results for the period ended June 30, 2009 and provide an update on recent corporate developments.

To access the conference call, please dial 1-877-407-4018 (USA) or 1-201-689-8471 (international). A replay of the call will be available from 11:00 a.m. ET on August 19, 2009 to September 2, 2009 at midnight. To access the replay, please dial 1-877-660-6853 (USA) or 1-201-612-7415 (international) and reference the account number 3055 and the access code 330444.

A live audio webcast of the call will also be available from the Investors section on the corporate web site at http://www.sinovac.com . A webcast replay can be accessed on the corporate website beginning August 19, 2009 and the replay will remain available for 30 days.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's commercialized vaccines include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). Panflu(TM), Sinovac's pandemic influenza vaccine (H5N1), has already been approved for government stockpiling. Sinovac is developing vaccines for Enterovirus 71, Universal Pandemic Influenza, Japanese encephalitis vaccine, and Human Rabies vaccine. Its wholly-owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccines.

    For more info
'/>"/>
SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
2. Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
3. Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1)
4. Sinovac Adjourns 2008 Annual General Meeting
5. Sinovac Receives Chinas First Influenza A (H1N1) Vaccine Order
6. Sinovac Completes Construction of H1N1 Virus Seed Bank
7. Sinovac Begins the Production of Influenza A (H1N1) Vaccine
8. Chinas Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation
9. Sinovac to Host Conference Call to Report First Quarter 2009 Financial Results
10. Sinovac Biotech Ltd. Files Annual Report on Form 20-F
11. Sinovac Initiates Preparatory Activities for Swine Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... zFlo Motion , a US leader ... exciting product from a new partner. STT-Systems has ... past 15 years, with offerings in the optical-motion capture, 3D ... system (inertial measurement unit), iSen, is opening eyes around the ...
(Date:1/22/2015)... 22, 2015 Controlled Substance Compliance Services ... helps companies check the legal requirements around using controlled ... China. , As their international operations expand and ... software solutions built as a result of the first ...
(Date:1/22/2015)... Diagenode, Inc., a leading global provider ... complete solutions for epigenetics research, recently launched a ... need for manual processing. The new ChIPettor System ... histones or transcription factors and a semi-automated pipette ...
(Date:1/22/2015)...   Cypher Genomics, Inc., the leading genome ... SQNM ), the leading molecular diagnostics company, today ... prenatal tests (NIPT). Through this agreement, Sequenom will ... advance analysis of clinically-relevant fetal sub-chromosomal variants detected ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Global Compliance Service for Controlled Substances to Expand to China 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
... 12, Shire plc (LSE: SHP)(NASDAQ: SHPGY )(TSX: SHQ),the ... on Thursday 21 February 2008., Results press ... GMT / 07:00 EST Investor meeting and conference ... Investor & Analyst meeting and conference call:, Matthew ...
... AMSTERDAM, February 12 Amsterdam Molecular,Therapeutics (Euronext: AMT), ... therapy,today announced that it will release its financial ... 20, 2008 at 7:30 am Central European Time,(CET). ... a conference call,at 10 am CET. Netherlands Dial ...
... NEW YORK, Feb. 12 Bristol-Myers Squibb,Company (NYSE: ... Directors,has elected James M. Cornelius chairman of the Board. ... 2006, will continue serving,in that role as well. Mr. ... be terminated. The Board also named Lewis B.,Campbell, chairman, ...
Cached Biology Technology:Full Year 2007 Results Date Notification - 21 February 2008 2Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board 2
(Date:12/17/2014)... and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ) has announced ... Home Button Synaptics Fingerprint Sensor Technology Analysis" report ... Based on a totally different sensing ... first time a fingerprint sensor in its product. ...
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM announced today ... to confirm its adherence to current U.S. Food and ... conduct regulated smart device and smart phone application trials ... quality. "HITLAB is determined to improve global ...
(Date:12/17/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) ... Sensor Market 2015-2019" report to their offering. ... major trend upcoming in this market is the increasing ... help in recording of patient data for quick and ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... that reproduce asexually by somatic cloning have special mechanisms ... the University of Gothenburg have shown how colony-forming ascidians ... protects DNA. This enzyme is more active also in ... clone themselves, in which part of an individual,s body ...
... The first research to actively analyze adult male sea ... link geography with pollutants has revealed the potential risks ... research, published today in Environmental Toxicology and Chemistry ... blood of both migratory and residential turtles. "The ...
... ORLANDO, Fla., April 20, 2011 After 30 years ... Perrott announces his retirement. Perrott served ... CEO in 1991. Under his tenure, Chip Supply grew ... as well as a leading global provider of high ...
Cached Biology News:Marine organisms with eternal life can solve the riddle of aging 2Satellite tracking of sea turtles reveals potential threat posed by manmade chemicals 2
Recombinant Rat Leptin, Ultra Pure...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: